← Leaderboards
Xaralabos Varelas
Boston University Medical Campus
$6,468,297
Attributed
$9,503,638
Total exposure
4
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.8M · FY2014–25$2M$1.5M$1M$500K$0
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$9,503,638 · 4
By mechanism
R01$9,050,075 · 3
R21$453,563 · 1
Top collaborators
- Maria A Kukuruzinska8 shared
- Stefano Monti8 shared
Most similar at Boston University Medical Campus
Same institution · by research overlap
- Stefano Monti$4,870,283
- Maria A Kukuruzinska$7,479,753
- Adeline Marie Matschulat$169,651
- Julia Berthet$137,665
- Anthony Spinella$161,206
Others in their field
Top investigators on “Molecular”
- David Heimbrook · Leidos Biomedical Research, Inc.$871,088,761
- Leonard Freedman · Leidos Biomedical Research, Inc.$468,573,385
- Richard Webby · St. Jude Children'S Research Hospital$254,843,170
- Larry Arthur$238,531,074
- Gregory H Reaman · National Childhood Cancer Foundation$230,630,913
- Ralph Parchment · Leidos Biomedical Research, Inc.$193,231,914
Research focus
MolecularMediatingInsightSignal TransductionMalignant NeoplasmsNuclearCellsPathway InteractionsBindingComplexResponsePhenotypeAffectArchitectureCell ProliferationMapsMouse ModelSignal PathwayBiochemicalGenetic TranscriptionOrganDefectMesenchymalEpithelial Cells
Grant awards (20)
Defining immune-evasive mechanical signaling in head and neck cancer$676,314
R01 · FY2025 · DE · contact PI
Defining the β-catenin/CBP-catenin/CBP axis in head and neck cancer$554,143
R01 · FY2025 · DE
Defining immune-evasive mechanical signaling in head and neck cancer$653,172
R01 · FY2024 · DE · contact PI
Defining the β-catenin/CBP-catenin/CBP axis in head and neck cancer$633,640
R01 · FY2024 · DE
Defining epithelial polarity cues that direct cell fate$480,869
R01 · FY2024 · HL · contact PI
Defining the β-catenin/CBP-catenin/CBP axis in head and neck cancer$669,143
R01 · FY2023 · DE
Defining epithelial polarity cues that direct cell fate$490,684
R01 · FY2023 · HL · contact PI
Defining the β-catenin/CBP-catenin/CBP axis in head and neck cancer$639,175
R01 · FY2022 · DE
Defining epithelial polarity cues that direct cell fate$490,684
R01 · FY2022 · HL · contact PI
Defining the β-catenin/CBP-catenin/CBP axis in head and neck cancer$563,548
R01 · FY2021 · DE
Defining epithelial polarity cues that direct cell fate$490,684
R01 · FY2021 · HL · contact PI
Enhancement and Cloud Deployment of CaDrA, a software tool for Candidate Driver Analysis of Multiomics Data$163,876
R01 · FY2021 · DE
Defining epithelial polarity cues that direct cell fate$490,684
R01 · FY2020 · HL · contact PI
Defining non-nuclear roles for Yap in the development of multi-ciliated cells$206,250
R21 · FY2019 · HD · contact PI
Defining epithelial cell polarity cues that direct cell fate$408,734
R01 · FY2018 · HL · contact PI
Defining non-nuclear roles for Yap in the development of multi-ciliated cells$247,313
R21 · FY2018 · HD · contact PI
Defining epithelial cell polarity cues that direct cell fate$408,737
R01 · FY2017 · HL · contact PI
Defining epithelial cell polarity cues that direct cell fate$408,739
R01 · FY2016 · HL · contact PI
Defining epithelial cell polarity cues that direct cell fate$404,561
R01 · FY2015 · HL · contact PI
Defining epithelial cell polarity cues that direct cell fate$422,688
R01 · FY2014 · HL · contact PI